Bullous Pemphigoid

Bullous pemphigoid is a chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Discover the latest research on bullous pemphigoid here.

June 23, 2020
Case Report

Nivolumab-Induced Bullous Pemphigoid Managed without Drug Withdrawal

Indian Journal of Dermatology
Mónica Munera-CamposCarlos Ferrándiz
July 6, 2020

Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era

Dermatologic Therapy
Seyyede Zeinab AzimiMaryam Daneshpazhooh
June 13, 2020

Diagnostic and Therapeutic Differences Between Immune Checkpoint Inhibitor-Induced and Idiopathic Bullous Pemphigoid: A Cross-Sectional Study

The British Journal of Dermatology
Gabriel E MolinaSteven T Chen
July 4, 2020

False-Negative Rate of Direct Immunofluorescence on Lower Extremities in Bullous Pemphigoid

The American Journal of Dermatopathology
David M PerryJohn C Maize
June 2, 2020
Case Report

Simultaneous Bullous Pemphigoid and Vitiligo Associated with Adalimumab Therapy in a Patient with Psoriasis Vulgaris

Indian Dermatology Online Journal
Andrés Tirado-Sánchez, Alexandro Bonifaz
June 5, 2020

Acquired Haemophilia A in DPP4 Inhibitor-induced Bullous Pemphigoid as Immune Reconstitution Syndrome

Acta Dermato-venereologica
Seiko SugiyamaYumi Aoyama
June 4, 2020
Case Report

Immunoglobulin M bullous pemphigoid: An enigma

JAAD Case Reports
Rosalie BaardmanGilles F H Diercks
June 22, 2020

Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps

Clinics in Dermatology
Renee M ThomasKiran Motaparthi
June 2, 2020
Open Access

Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy

The British Journal of Dermatology
A CarugnoP Vezzoli
June 14, 2020
Case Report

Mycosis fungoides bullosa: A rare clinical presentation

Annales de dermatologie et de vénéréologie
C JuzotG Quéreux
July 8, 2020

A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor

Immunological Medicine
Kaori SawadaYasuhito Hamaguchi
May 18, 2020
Open Access

Reply to: "Comment on Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes"

Journal of the American Academy of Dermatology
Caroline A NelsonNicole R LeBoeuf
July 6, 2020

Nivolumab - associated pemphigoid - like blistering dermatosis after sun exposure

Dermatologic Therapy
Nicolas KlugerKatriina Lappalainen
May 24, 2020
Case Report

A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis

Multiple Sclerosis and Related Disorders
Doruk ArslanMeryem Aslı Tuncer
June 27, 2020

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients

The Journal of Dermatological Treatment
Nika KianfarMaryam Daneshpazhooh
July 6, 2020

Total IgE, eosinophils and interleukins 16, 17A and 23 correlations in severe bullous pemphigoid, and treatment implications

Dermatologic Therapy
Florentina DelliDemetrios Ioannides
June 17, 2020

Acetazolamide: a new trigger for bullous pemphigoid?

European Journal of Dermatology : EJD
Emanuele CozzaniAurora Parodi
June 20, 2020
Open Access

Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center

Scientific Reports
Denis Miyashiro, José Antonio Sanches

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.


Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

© 2020 Meta ULC. All rights reserved